نتایج جستجو برای: aml

تعداد نتایج: 12334  

2016
Hasan Mahmud Steven M. Kornblau Arja ter Elst Frank J. G. Scherpen Yi Hua Qiu Kevin R. Coombes Eveline S. J. M. de Bont

The epidermal growth factor receptor (EGFR) inhibitor erlotinib has been shown to induce complete remission of acute myeloid leukemia (AML) in two patients with concurrent lung cancer and raised attention for a role of EGFR in AML whereas a recent phase II clinical study with gefitinib in AML demonstrated a negative result on the outcome. However, from several studies, EGFR expression in AML is...

Journal: :Blood 2015
R Coleman Lindsley Brenton G Mar Emanuele Mazzola Peter V Grauman Sarah Shareef Steven L Allen Arnaud Pigneux Meir Wetzler Robert K Stuart Harry P Erba Lloyd E Damon Bayard L Powell Neal Lindeman David P Steensma Martha Wadleigh Daniel J DeAngelo Donna Neuberg Richard M Stone Benjamin L Ebert

Acute myeloid leukemia (AML) can develop after an antecedent myeloid malignancy (secondary AML [s-AML]), after leukemogenic therapy (therapy-related AML [t-AML]), or without an identifiable prodrome or known exposure (de novo AML). The genetic basis of these distinct pathways of AML development has not been determined. We performed targeted mutational analysis of 194 patients with rigorously de...

Journal: :Blood 2003
Claudia Schoch Susanne Schnittger Mirjam Klaus Wolfgang Kern Wolfgang Hiddemann Torsten Haferlach

Acute myeloid leukemia (AML) cases with 11q23 abnormalities involving the MLL gene comprise one category of recurring genetic abnormalities in the WHO classification. In an unselected series of 1897 AML cases, 54 patients with an 11q23/MLL rearrangement were identified, resulting in an incidence of 2.8%. The incidence of AML with MLL rearrangement was significantly higher in therapy-related AML...

2017
Hongchao Lv Mingming Zhang Zhenwei Shang Jin Li Shanshan Zhang Duan Lian Ruijie Zhang

Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, and generally considered to be caused by environment and genetic factors. In this study, we combined a genome-wide haplotype association study (GWHAS) and gene prioritization strategy to mine AML-related genetic affect factors and understand its pathogenesis. A total of 175 AML patients were downloaded from the public ...

2018
Jae-Sook Ahn Hyeoung-Joon Kim Yeo-Kyeoung Kim Seung-Shin Lee Seo-Yeon Ahn Sung-Hoon Jung Deok-Hwan Yang Je-Jung Lee Hee Jeong Park Ja-Yeon Lee Seung Hyun Choi Chul Won Jung Jun-Ho Jang Hee Je Kim Joon Ho Moon Sang Kyun Sohn Yoo Jin Lee Jong-Ho Won Sung-Hyun Kim Zhaolei Zhang TaeHyung Kim Dennis Dong Hwan Kim

This study was performed to assess if a recently recommended genomic classification is predictive in patients with normal-karyotype (NK) acute myeloid leukemia (AML). A total of 393 patients were included. Analysis of genetic mutations was performed using targeted resequencing with an Illumina Hiseq 2000. We identified driver mutations across 40 genes, with one or more driver mutations identifi...

2015
N. Geetha K.P. Sreelesh M. J. Priya V.S. Lali N. Rekha

Acute myeloid leukemia (AML) M6 is a rare form of AML accounting for < 5 % of all AML. Extramedullary involvement is very rarely seen in this entity. Skeletal lesion has not been described in AML M6 before. We discuss the case of a 17 year old boy with AML M6, who presented with osteolytic lesion of right humerus. He was treated with induction and consolidation chemotherapy. The present case is...

ژورنال: :فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران 0
همت یار معصومه hemmatyar m assistant professor, department of pediatrics, javaheri hospital, islamic azad university, tehran medical unitاستادیار، گروه اطفال، دانشگاه آزاد اسلامی، واحد پزشکی تهران حاجی نقدی مرجان haji-naghdi m general practitionerپزشک عمومی

سابقه و هدف: لوسمی شایعترین بدخیمی در کودکان است و نوع لنفوبلاستیک حاد 5 برابر شایعتر از نوع میلوسیتیک حاد می باشد. این مطالعه به منظور مقایسه شیوع سنی، جنسی و چگونگی تظاهرات بالینی در بیماران مبتلا به لوسمی حاد لنفوبلاستیک (all)و لوسمی حاد میلوسیتیک (aml)انجام گردید.روش بررسی: این یک مطالعه توصیفی تحلیلی است که بر روی 70 بیمار مبتلا بهall و 70 بیمار مبتلا بهaml که در مرکز طبی کودکان بستری بودن...

Journal: :international journal of hematology-oncology and stem cell research 0
zohreh sanaat hematology- oncology research center, tabriz university of medical sciences, tabriz, iran yashar amizadeh hematology- oncology research center, tabriz university of medical sciences, tabriz, iran akbar movasagpour akbari hematology- oncology research center, tabriz university of medical sciences, tabriz, iran roya dolatkhah hematology- oncology research center, tabriz university of medical sciences, tabriz, iran

introduction: acute myeloid leukemia (aml) is a clonal disease characterized by heterogeneous involvement of hematopoietic bone marrow cell populations. in aml patients, a variety of clinical and biologic parameters, including surface markers, have been examinedfor potential value in predicting treatment response and survival. by checking the myeloid, lymphoid and nonspecific markers on the bla...

2017
Oren Pleniceanu Racheli Shukrun Dorit Omer Einav Vax Itamar Kanter Klaudyna Dziedzic Naomi Pode-Shakked Michal Mark-Daniei Sara Pri-Chen Yehudit Gnatek Hadas Alfandary Nira Varda-Bloom Dekel D Bar-Lev Naomi Bollag Rachel Shtainfeld Leah Armon Achia Urbach Tomer Kalisky Arnon Nagler Orit Harari-Steinberg Jack L Arbiser Benjamin Dekel

Angiomyolipoma (AML), the most common benign renal tumor, can result in severe morbidity from hemorrhage and renal failure. While mTORC1 activation is involved in its growth, mTORC1 inhibitors fail to eradicate AML, highlighting the need for new therapies. Moreover, the identity of the AML cell of origin is obscure. AML research, however, is hampered by the lack of in vivo models. Here, we esta...

Journal: :Blood 2012
Ursula Creutzig Marry M van den Heuvel-Eibrink Brenda Gibson Michael N Dworzak Souichi Adachi Eveline de Bont Jochen Harbott Henrik Hasle Donna Johnston Akitoshi Kinoshita Thomas Lehrnbecher Guy Leverger Ester Mejstrikova Soheil Meshinchi Andrea Pession Susana C Raimondi Lillian Sung Jan Stary Christian M Zwaan Gertjan J L Kaspers Dirk Reinhardt

Despite major improvements in outcome over the past decades, acute myeloid leukemia (AML) remains a life-threatening malignancy in children, with current survival rates of ∼70%. State-of-the-art recommendations in adult AML have recently been published in this journal by Döhner et al. The primary goal of an international expert panel of the International BFM Study Group AML Committee was to set...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید